Abstract
Minimal Residual Disease Assessment Using Euroflow-NGF in Patients with Multiple Myeloma Treated with a Combination of Carfilzomib, Lenalidomide, and Dexamethasone (KRD)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have